AAAAAA

   
Results: 1-21 |
Results: 21
CDNA CLONING AND EXPRESSION OF A NEW FORM OF HUMAN ARYL SULFOTRANSFERASE
Authors: ZHU XY VERONESE ME IOCCO P MCMANUS ME
Citation: Xy. Zhu et al., CDNA CLONING AND EXPRESSION OF A NEW FORM OF HUMAN ARYL SULFOTRANSFERASE, International journal of biochemistry & cell biology, 28(5), 1996, pp. 565-571
HUMAN CYTOCHROME-P450 ISOFORM SPECIFICITY IN THE REGIOSELECTIVE METABOLISM OF TOLUENE AND O-XYLENE, M-XYLENE AND P-XYLENE
Authors: TASSANEEYAKUL W BIRKETT DJ EDWARDS JW VERONESE ME TASSANEEYAKUL W TUKEY RH MINERS JO
Citation: W. Tassaneeyakul et al., HUMAN CYTOCHROME-P450 ISOFORM SPECIFICITY IN THE REGIOSELECTIVE METABOLISM OF TOLUENE AND O-XYLENE, M-XYLENE AND P-XYLENE, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 101-108
PHOTOAFFINITY-LABELING OF HUMAN RECOMBINANT SULFOTRANSFERASES WITH 2-AZIDOADENOSINE 3',5'-[5'-P-32]BISPHOSPHATE
Authors: RADOMINSKA A DRAKE RR ZHU XY VERONESE ME LITTLE JM NOWELL S MCMANUS ME LESTER R FALANY CN
Citation: A. Radominska et al., PHOTOAFFINITY-LABELING OF HUMAN RECOMBINANT SULFOTRANSFERASES WITH 2-AZIDOADENOSINE 3',5'-[5'-P-32]BISPHOSPHATE, The Journal of biological chemistry, 271(6), 1996, pp. 3195-3199
CYTOCHROME P450, 1A2, AND 2C9 ARE RESPONSIBLE FOR THE HUMAN HEPATIC O-DEMETHYLATION OF R-NAPROXEN AND S-NAPROXEN
Authors: MINERS JO COULTER S TUKEY RH VERONESE ME BIRKETT DJ
Citation: Jo. Miners et al., CYTOCHROME P450, 1A2, AND 2C9 ARE RESPONSIBLE FOR THE HUMAN HEPATIC O-DEMETHYLATION OF R-NAPROXEN AND S-NAPROXEN, Biochemical pharmacology, 51(8), 1996, pp. 1003-1008
ALLELIC VARIANTS OF HUMAN CYTOCHROME-P450 2C9 - BACULOVIRUS-MEDIATED EXPRESSION, PURIFICATION, STRUCTURAL CHARACTERIZATION, SUBSTRATE STEREOSELECTIVITY, AND PROCHIRAL SELECTIVITY OF THE WILD-TYPE AND I359L MUTANT FORMS
Authors: HAINING RL HUNTER AP VERONESE ME TRAGER WF RETTIE AE
Citation: Rl. Haining et al., ALLELIC VARIANTS OF HUMAN CYTOCHROME-P450 2C9 - BACULOVIRUS-MEDIATED EXPRESSION, PURIFICATION, STRUCTURAL CHARACTERIZATION, SUBSTRATE STEREOSELECTIVITY, AND PROCHIRAL SELECTIVITY OF THE WILD-TYPE AND I359L MUTANT FORMS, Archives of biochemistry and biophysics, 333(2), 1996, pp. 447-458
HUMAN HEPATIC CYTOCHROME-P450 2C9 CATALYZES THE RATE-LIMITING PATHWAYOF TORSEMIDE METABOLISM
Authors: MINERS JO REES DLP VALENTE L VERONESE ME BIRKETT DJ
Citation: Jo. Miners et al., HUMAN HEPATIC CYTOCHROME-P450 2C9 CATALYZES THE RATE-LIMITING PATHWAYOF TORSEMIDE METABOLISM, The Journal of pharmacology and experimental therapeutics, 272(3), 1995, pp. 1076-1081
DIRECT CHARACTERIZATION OF THE SELECTIVITY OF FURAFYLLINE AS AN INHIBITOR OF HUMAN CYTOCHROMES P450 1A1 AND 1A2
Authors: TASSANEEYAKUL W BIRKETT DJ VERONESE ME MCMANUS ME TUKEY RH MINERS JO
Citation: W. Tassaneeyakul et al., DIRECT CHARACTERIZATION OF THE SELECTIVITY OF FURAFYLLINE AS AN INHIBITOR OF HUMAN CYTOCHROMES P450 1A1 AND 1A2, Pharmacogenetics, 4(5), 1994, pp. 281-284
DIAZEPAM METABOLISM BY HUMAN LIVER-MICROSOMES IS MEDIATED BY BOTH S-MEPHENYTOIN HYDROXYLASE AND CYP3A ISOFORMS
Authors: ANDERSSON T MINERS JO VERONESE ME BIRKETT DJ
Citation: T. Andersson et al., DIAZEPAM METABOLISM BY HUMAN LIVER-MICROSOMES IS MEDIATED BY BOTH S-MEPHENYTOIN HYDROXYLASE AND CYP3A ISOFORMS, British journal of clinical pharmacology, 38(2), 1994, pp. 131-137
IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING SECONDARY OMEPRAZOLE METABOLISM
Authors: ANDERSSON T MINERS JO VERONESE ME BIRKETT DJ
Citation: T. Andersson et al., IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING SECONDARY OMEPRAZOLE METABOLISM, British journal of clinical pharmacology, 37(6), 1994, pp. 597-604
IN-VITRO PROGUANIL ACTIVATION TO CYCLOGUANIL BY HUMAN LIVER-MICROSOMES IS MEDIATED BY CYP3A ISOFORMS AS WELL AS BY S-MEPHENYTOIN HYDROXYLASE
Authors: BIRKETT DJ REES D ANDERSSON T GONZALEZ FJ MINERS JO VERONESE ME
Citation: Dj. Birkett et al., IN-VITRO PROGUANIL ACTIVATION TO CYCLOGUANIL BY HUMAN LIVER-MICROSOMES IS MEDIATED BY CYP3A ISOFORMS AS WELL AS BY S-MEPHENYTOIN HYDROXYLASE, British journal of clinical pharmacology, 37(5), 1994, pp. 413-420
FUNCTIONAL-CHARACTERIZATION OF 2 HUMAN SULFOTRANSFERASE CDNAS THAT ENCODE MONOAMINE-SULFATING AND PHENOL-SULFATING FORMS OF PHENOL SULFOTRANSFERASE - SUBSTRATE KINETICS, THERMAL-STABILITY AND INHIBITOR-SENSITIVITY STUDIES
Authors: VERONESE ME BURGESS W ZHU XY MCMANUS ME
Citation: Me. Veronese et al., FUNCTIONAL-CHARACTERIZATION OF 2 HUMAN SULFOTRANSFERASE CDNAS THAT ENCODE MONOAMINE-SULFATING AND PHENOL-SULFATING FORMS OF PHENOL SULFOTRANSFERASE - SUBSTRATE KINETICS, THERMAL-STABILITY AND INHIBITOR-SENSITIVITY STUDIES, Biochemical journal, 302, 1994, pp. 497-502
HETEROLOGOUS SYSTEMS FOR EXPRESSION OF MAMMALIAN SULFOTRANSFERASES
Authors: VERONESE ME BURGESS W CRUICKSHANK D SANSOM L ZHU XY MCMANUS ME
Citation: Me. Veronese et al., HETEROLOGOUS SYSTEMS FOR EXPRESSION OF MAMMALIAN SULFOTRANSFERASES, Chemico-biological interactions, 92(1-3), 1994, pp. 77-85
CAFFEINE METABOLISM BY HUMAN HEPATIC CYTOCHROMES P450 - CONTRIBUTIONSOF 1A2, 2E1 AND 3A ISOFORMS
Authors: TASSANEEYAKUL W BIRKETT DJ MCMANUS ME TASSANEEYAKUL W VERONESE ME ANDERSSON T TUKEY RH MINERS JO
Citation: W. Tassaneeyakul et al., CAFFEINE METABOLISM BY HUMAN HEPATIC CYTOCHROMES P450 - CONTRIBUTIONSOF 1A2, 2E1 AND 3A ISOFORMS, Biochemical pharmacology, 47(10), 1994, pp. 1767-1776
IN-VITRO APPROACHES CAN PREDICT HUMAN DRUG-METABOLISM
Authors: BIRKETT DJ MACKENZIE PI VERONESE ME MINERS JO
Citation: Dj. Birkett et al., IN-VITRO APPROACHES CAN PREDICT HUMAN DRUG-METABOLISM, Trends in pharmacological sciences, 14(8), 1993, pp. 292-294
TOLBUTAMIDE HYDROXYLATION IN HUMANS - LACK OF BIMODALITY IN 106 HEALTHY-SUBJECTS
Authors: VERONESE ME MINERS JO REES DLP BIRKETT DJ
Citation: Me. Veronese et al., TOLBUTAMIDE HYDROXYLATION IN HUMANS - LACK OF BIMODALITY IN 106 HEALTHY-SUBJECTS, Pharmacogenetics, 3(2), 1993, pp. 86-93
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR HUMAN LIVER MICROSOMAL OMEPRAZOLE METABOLISM
Authors: ANDERSSON T LAGERSTROM PO MINERS JO VERONESE ME WEIDOLF L BIRKETT DJ
Citation: T. Andersson et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR HUMAN LIVER MICROSOMAL OMEPRAZOLE METABOLISM, Journal of chromatography. Biomedical applications, 619(2), 1993, pp. 291-297
IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM
Authors: ANDERSSON T MINERS JO VERONESE ME TASSANEEYAKUL W TASSANEEYAKUL W MEYER UA BIRKETT DJ
Citation: T. Andersson et al., IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM, British journal of clinical pharmacology, 36(6), 1993, pp. 521-530
SPECIFICITY OF SUBSTRATE AND INHIBITOR PROBES FOR HUMAN CYTOCHROMES-P450 1A1 AND 1A2
Authors: TASSANEEYAKUL W BIRKETT DJ VERONESE ME MCMANUS ME TUKEY RH QUATTROCHI LC GELBOIN HV MINERS JO
Citation: W. Tassaneeyakul et al., SPECIFICITY OF SUBSTRATE AND INHIBITOR PROBES FOR HUMAN CYTOCHROMES-P450 1A1 AND 1A2, The Journal of pharmacology and experimental therapeutics, 265(1), 1993, pp. 401-407
VALIDATION OF 4-NITROPHENOL AS AN IN-VITRO SUBSTRATE PROBE FOR HUMAN LIVER CYP2E1 USING CDNA EXPRESSION AND MICROSOMAL KINETIC TECHNIQUES
Authors: TASSANEEYAKUL W VERONESE ME BIRKETT DJ GONZALEZ FJ MINERS JO
Citation: W. Tassaneeyakul et al., VALIDATION OF 4-NITROPHENOL AS AN IN-VITRO SUBSTRATE PROBE FOR HUMAN LIVER CYP2E1 USING CDNA EXPRESSION AND MICROSOMAL KINETIC TECHNIQUES, Biochemical pharmacology, 46(11), 1993, pp. 1975-1981
IDENTIFICATION OF 2 HUMAN BRAIN ARYL SULFOTRANSFERASE CDNAS
Authors: ZHU XY VERONESE ME BERNARD CCA SANSOM LN MCMANUS ME
Citation: Xy. Zhu et al., IDENTIFICATION OF 2 HUMAN BRAIN ARYL SULFOTRANSFERASE CDNAS, Biochemical and biophysical research communications, 195(1), 1993, pp. 120-127
MOLECULAR CHARACTERIZATION OF A HUMAN ARYL SULFOTRANSFERASE CDNA
Authors: ZHU XY VERONESE ME SANSOM LN MCMANUS ME
Citation: Xy. Zhu et al., MOLECULAR CHARACTERIZATION OF A HUMAN ARYL SULFOTRANSFERASE CDNA, Biochemical and biophysical research communications, 192(2), 1993, pp. 671-676
Risultati: 1-21 |